Teva Pharmaceutical Industries Limited: Teva to Present Firs

The study evaluated the effect of the ProAir Digihaler System on asthma control versus standard of care as measured by the Asthma Control Test, and explored use of the ProAir Digihaler System to help

Related Keywords

United States , Spain , Barcelona , Comunidad Autonoma De Cataluna , Proair Dighaler , Doris Yiu , Proair Digihaler , Yael Ashman , Randall Brown , Yonatan Beker , Affairs At Teva , Teva Pharmaceutical Industries Ltd , Digital Health Platform , International Congress , Digital Health , European Respiratory Society , Teva Pharmaceuticals United States Inc , Proair Digihaler System , Asthma Control Test , Pharmaceuticals United States , Teva Pharmaceutical Industries , Digihaler System , Global Lead , Respiratory Medical Affairs , Reliever Based Digital System , Asthma Control , Remote Monitoring , Respiratory Patients , Digihaler Inhalers , Inhalation Powder , Air Digihaler Indications , Air Digihaler , Discontinue Proair Digihaler , Anti Inflammatory Agents , Not Exceed Recommended Dose , Oxidase Inhibitors , Tricyclic Antidepressants , Pharmaceutical Industries , Private Securities Litigation Reform Act , Quarterly Report , Annual Report , Teva , Harmaceutical , Industries , Imited , Present , First , Data , Rom , Onnect1 , Linical , Trial , Proair , Igihaler , Albuterol , Sulfate , Inhalation , Powder , European , Espiratory , Society , Nternational ,